Skip to main content
Signal8

Cohen Jonathan M

SEC insider (Form 3/4/5 filer). CIK 0002111543. Chief Executive Officer at 20/20 Biolabs, Inc. (AIDX). 1 reported Form 4/5 transaction since Sep 2024; latest on Mar 3, 2026. Located in GAITHERSBURG, MD.

Companies Cohen Jonathan M has filed insider reports for

  • 20/20 Biolabs, Inc. (AIDX): Director, Officer, 10% Owner, Chief Executive Officer
Cohen Jonathan M profile photo

Cohen Jonathan M

CIK: 0002111543

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

20/20 Biolabs, Inc. logo
AIDX

20/20 Biolabs, Inc.

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • 20/20 Biolabs, Inc. logo
    AIDX

    20/20 Biolabs, Inc.

    Mar 3, 2026
    Award

    Stock Option

    Direct
    352.9K shares-

1-1 of 1